December 11, 2018
Schrödinger and TB Alliance Announce Collaboration to Accelerate Tuberculosis Drug Discovery
Partnership merges Schrödinger’s advanced modeling capabilities with TB Alliance’s expertise in tuberculosis biology to accelerate the development of next-generation treatments
December 4, 2018
Global TB Research Funding Continues to Fall Short
Statement on TAG Report on TB Research Funding Trends
November 28, 2018
TB Alliance Receives GHTC Partnership Award for Development of Child-Friendly TB Medicines
Fixed dose combination medicines now available across 85 countries and set to reach first 800,000 children
November 26, 2018
Closing the TB Funding Gap
November 19, 2018
TB Alliance Statement on EMA Approval of Fexinidazole
Regulatory approval of all-oral sleeping sickness medication is a global health breakthrough
October 24, 2018
TB Alliance Joins Innovative Medicines Initiative to Accelerate Development of New TB Cures
European Public-Private Partnership Enables Research to Combat Health Threats, including Drug-Resistant Tuberculosis
September 26, 2018
Statement on UN High-Level Meeting on TB
The world is listening and expecting true commitment and change
September 19, 2018
TB Alliance and Liverpool School of Tropical Medicine Collaborate to Develop New TB Therapies
New partnership supported by Medical Research Council to research drug regimens to fight drug-resistant tuberculosis
September 18, 2018
Once Again, New TB Numbers Underscore the Need for New Treatments
Statement from TB Alliance on WHO Global TB Report 2018
August 28, 2018